Signaling Pathways - S-nitrosoglutathione reductase - CETP - Insulin and Insulin-like Receptors - EZH1
清除全部
-
B4678 CPI-1691 CitationTarget: EZH2|EZH1Summary: EZH2抑制剂 -
B1111 N6022Target: S-nitrosoglutathione reductaseSummary: GSNOR抑制剂 -
B1583 UNC19992 CitationTarget: EZH2|EZH1Summary: EZH2抑制剂 -
A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: ATP竞争性IGF-IR/IR/ALK抑制剂 -
A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: IGF-1R/IR 选择性抑制剂 -
A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: 有效的、选择性的IGF-1R和InsR抑制剂 -
A3608 MK 0893Target: Insulin and Insulin-like Receptors|Glucagon ReceptorsSummary: 胰高血糖素受体/ IGF-1R拮抗剂 -
A4377 Evacetrapib (LY2484595)Target: CETPSummary: 强效的CETP选择性抑制剂 -
A4375 Anacetrapib (MK-0859)1 Citation中文名: 安塞曲匹Target: CETPSummary: RhCETP/突变型 CETP(C13S) 抑制剂 -
A4302 Rosiglitazone maleate中文名: 马来酸罗格列酮Target: Insulin and Insulin-like ReceptorsSummary: PPARγ激动剂，有效的胰岛素敏化剂